A bill passed by the Colorado Senate to create an appropriate regulatory framework for legal psychedelics has been advanced in two Colorado House committees.
The House Finance Committee received the bill from Senate President Steve Fenberg, (D), and advanced it with amendments on Thursday in a vote of 8-2. The Appropriations committee approved it with minor technical changes on Friday. It then went to the House for consideration in second reading.
The measure, which was introduced in early May, has been moving quickly. Lawmakers are working to pass it by the end of this legislative session. The measure was passed quickly by two Senate panels before it was approved on Tuesday.
The bill aims to establish regulations for the psychedelics law voters approved at the ballot box last year. It focuses primarily on rules for the use of the substances in licensed centers under the supervision of facilitators. has received mixed feedback from stakeholders and advocates .
During Thursday’s committee, Rep. Judy Amabile said: “My conclusion from the testimony was that ballot measure 12 is controversial.” It has many aspects that some people enjoy. There are aspects of the movie that people who enjoy certain parts don’t like. It has elements that no one likes.”
The lawmaker stated, “This issue was voted upon by all of Colorado and the voters spoke. They passed ballot measure 122, and we are happy to implement their will.” Now it’s our job, as the legislature, to implement the will the voters.”
She said that the bill was about “trusting that the voters have expressed what they want, and implementing the measure in a manner that is faithful to the will and wishes of the voters while also providing us with a framework we can legally and administrativly implement.”
She said, “Now that we have it, we need to implement it. We are working to do this in a way that is safe and efficient.”
The ballot measure asked for the establishment of an advisory council that would develop regulatory recommendations in order to inform a more comprehensive legislation covering this access. But as the process continues the Senate President filed a separate law last week to set rules.
The bill aims to establish policies for “healing centres” where adults over 21 could receive psychedelic treatments, tighten rules on cultivation, and set up licensing requirements. It also outlines state agency regulatory duties and penalties for unapproved activities.
The House Finance Committee adopted several amendments during its hearing on Thursday. These included adding language clarifying that the use of psychedelics is not a violation to probation or parole, revising provisions regarding record sealing to ensure that people cannot be charged for trying to clear up their convictions and giving district attorneys an exact period of 42-days to object to motions of sealing records.
A second amendment adopted makes a number of changes. These include: requiring that psychedelic facilitators inform participants when they are not licensed, requiring that psychedelic facilitators comply with the general fingerprinting rules of the state for practitioners, clarifying that parental rights protections are only limited where the safety and health of a child are threatened and changing the definitions of business entities involved in psychedelics as requested by local officials.
The panel, at its meeting on Friday, approved a technical change before sending the bill to the floor. The legislation will have to be re-sent to the Senate to receive their approval before it can potentially reach the governor.
The bill as amended contains the following key elements:
The bill would continue the policy that was approved by voters in a ballot measure, which allowed adults over 21 to possess psilocybin (as well as ibogaine and mescaline not derived from peyote), DMT, and psilocyn.
A $100 fine would be imposed on anyone who is caught using psychedelics in public or underage.
Adults would only be allowed to grow natural psychedelics in a private home, within an enclosed area that was not larger than 12 feet by 12 feet. This is unless the locality has enacted policies that allow for bigger grows. A $1,000 fine would be imposed on anyone who cultivates beyond the limits.
People with previous convictions for psychedelic activities would be eligible for sealing their records.
The Department of Revenue’s new Division of Natural Medicine would be responsible for regulating therapeutic programs and issuing licenses to cultivators, manufacturers and testing facilities, as well as healing centers. This is a difference to the original initiative which gave the primary responsibilities of the Department of Regulatory Agencies.
DORA would create a federally recognized American Tribes and Indigenous Community Working Group, which was not included in the ballot initiative. This group will identify and address any unintended effects of the reform.
The law clarifies that the use of synthetic psychedelics is not allowed. Possession of psychedelics containing “hazardous substances” such as solvents is a Class 2 crime.
The bill allows for the addition of additional psychedelics to healing centers. Initially, only psilocybin or psilocyn can be used at these facilities. The bill is different from the ballot measure because regulators can authorize the supervised usage of ibogaine in the facilities at any point, instead of waiting until June 1, 2026 as it was the case with mescaline or DMT.
Four categories of licenses would exist: Healing centers, cultivation sites, product manufacturers, and testing facilities.
The bill retains the provisions of the ballot measure to prevent localities from prohibiting healing centers. However, it says that they can enact regulations governing when, where and how they operate.
The date by which regulators must begin accepting and reviewing applications for licenses will be moved from September 30th, 2024 to December 31st, 2024.
In a partial solution to the federal 280E provisions, licensed psychedelic businesses can deduct their expenses from state taxes.
Marijuana Moment tracks more than 1,000 cannabis and drug policy bills that have been introduced in state legislatures, and Congress. Patreon supporters who pledge at least $25/month gain access to our interactive charts, maps and hearing calendar.
Discover more about our marijuana bills tracker. Become a Patreon supporter to gain access.
—
The findings section of the bill notes that, “although natural medicine may have tremendous potential for treating mental health conditions, healing and spiritual growth, it must be balanced against the potential health and safety hazards that it might pose to consumers, as well as cultural harms that it might cause to indigenous and traditional groups that are connected to natural medicine.”
It states that “considerable harm could occur to indigenous peoples, communities, cultures and religions, if natural medicines are overly commodified and commercialized in a way that erases important cultural and religious context.”
Early reactions to the bill have been mixed. Some supporters of the bill are tentatively in favor, while others are strongly against it because they believe that the regulations are excessive.
During a hearing in a Senate committee last week, the Senate President said that he felt that the implementation legislation “hit the right balance”.
He said, “I believe we are implementing 122 in its spirit.” “I believe we are doing it in a reasonable way to protect consumers and provide clarity for people–both for regular citizens and for law enforcement as they proceed down this road.”
In Colorado, on Monday the governor announced that the state will launch a loan program to support marijuana businesses with a social equity component .
Marijuana Advocates And Industry Groups Respond To Marijuana Bank Bill Refiling As A Key Senator Raised Early Concerns
The article Colorado House committees approve Senate-passed Psychedelics Regulating Bill, sending it to the floor first appeared on Marijuana Moment.
